2021 annual financial data
Immix Biopharma 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -1,352,014 USD and net income was -24,383,879 USD.
Operating cash flow was -1,589,307 USD.
Get free Immix Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -1,352,014 USD
- Net income
- -24,383,879 USD
- Operating cash flow
- -1,589,307 USD